Back to Trades
Total Value
$426.8K
Filing Date
Jun 25, 2026
1 transaction
Trade Summary
On Jun 23, 2026, Walker Maria C, Insider, reported $426.8K of MapLight Therapeutics, Inc. (MPLT) across 1 transaction. The filing covers Voting Common Stock and reflects balanced net activity of $0. Reported prices ranged from $28.64. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- MapLight Therapeutics, Inc.
- Ticker Symbol
- MPLT
- CIK
- 0001770069
Insider Information
- Name
- Walker Maria C
- Role
- Insider
- Location
- REDWOOD CITY, CA
Filing Details
- Filing Date
- Jun 25, 2026
- Transaction Date
- Jun 23, 2026
- Accession Number
- 0001826519-26-000002
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jun 23, 2026 | Voting Common Stock | 3,932 | — | Grant/Award | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jun 23, 2026 | MPLT derivative | 14,902 | $28.64 | Grant/Award | $426.8K |
Want live alerts when Walker Maria C trades again?
Download Insider Trades to track MPLT, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.
- (F2)Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
- (F3)Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.